Non-monotonic dose responses are critical in the risk assessment of chemicals, particularly in endocrine disruptors. These substances can cause effects at low doses that do not predictably increase with higher doses, complicating traditional risk assessment models. Understanding NMDRs is essential for regulatory agencies and public health professionals to ensure safe exposure limits are established.
